BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 10096477)

  • 1. Eighteen-year follow up after Hancock II bioprosthesis insertion.
    Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
    J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Mitroflow pericardial bioprosthesis. Comparison of early clinical performance in aortic and mitral positions.
    Jamieson WR; Pelletier LC; Gerein AN; Pomar J
    Can J Surg; 1992 Apr; 35(2):159-64. PubMed ID: 1562925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year evaluation of the Carpentier-Edwards porcine bioprosthesis.
    Jamieson WR; Pelletier LC; Janusz MT; Chaitman BR; Tyers FO; Miyagishima RT
    J Thorac Cardiovasc Surg; 1984 Sep; 88(3):324-33. PubMed ID: 6381888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical durability of the Hancock porcine bioprosthetic valve.
    Oyer PE; Miller DC; Stinson EB; Reitz BA; Moreno-Cabral RJ; Shumway NE
    J Thorac Cardiovasc Surg; 1980 Dec; 80(6):824-33. PubMed ID: 7431981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Medtronic Intact porcine bioprosthesis: clinical performance to eight years.
    Munro AI; Jamieson WR; Tyers GF; Burr LH
    J Heart Valve Dis; 1994 Nov; 3(6):634-40. PubMed ID: 8000606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carpentier-Edwards bioprosthesis: a 7-year follow-up in 361 patients.
    Zussa C; Del Ponte S; Ottino GM; Pansini S; Zattera G; Morea M
    Thorac Cardiovasc Surg; 1986 Aug; 34(4):252-7. PubMed ID: 2429394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hancock II bioprosthesis at ten years.
    David TE; Armstrong S; Sun Z
    Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S229-34. PubMed ID: 7646164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six years' experience with the Omnicarbon valve prosthesis.
    Otaki M; Kitamura N
    Cardiovasc Surg; 1993 Oct; 1(5):594-8. PubMed ID: 8076103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mitroflow pericardial valve: clinical performance to 10 years.
    Mazzucotelli JP; Bertrand PC; Loisance DY
    J Heart Valve Dis; 1995 Jul; 4(4):407-13. PubMed ID: 7582152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 5-year follow-up of the Medtronic-Hall valve: survival and thromboembolism.
    Semb BK; Hall KV; Nitter-Hauge S; Abdelnoor M
    Thorac Cardiovasc Surg; 1983 May; 31 Spec 2():61-5. PubMed ID: 6192536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five- to eight-year follow-up of patients with the Hancock cardiac bioprosthesis.
    Gallo I; Ruiz B; Duran CM
    J Thorac Cardiovasc Surg; 1983 Dec; 86(6):897-902. PubMed ID: 6645592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early mechanical failures of the Hancock pericardial xenograft.
    Bortolotti U; Milano A; Thiene G; Guerra F; Mazzucco A; Valente M; Talenti E; Gallucci V
    J Thorac Cardiovasc Surg; 1987 Aug; 94(2):200-7. PubMed ID: 3613618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valve-related complications with the Hancock I porcine bioprosthesis. A twelve- to fourteen-year follow-up study.
    Bernal JM; Rabasa JM; Cagigas JC; Echevarria JR; Carrion MF; Revuelta JM
    J Thorac Cardiovasc Surg; 1991 May; 101(5):871-80. PubMed ID: 2023444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic valve replacement with the Hancock standard, Björk-Shiley, and Lillehei-Kaster prostheses. A comparison based on follow-up from 1 to 15 years.
    Milano AD; Bortolotti U; Mazzucco A; Guerra F; Magni A; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Jul; 98(1):37-47. PubMed ID: 2739424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six years of experience with the St. Jude Medical valvular prosthesis.
    Arom KV; Nicoloff DM; Kersten TE; Northrup WF; Lindsay WG
    Circulation; 1985 Sep; 72(3 Pt 2):II153-8. PubMed ID: 3875432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
    Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hancock II porcine bioprosthesis. A preliminary report.
    Bortolotti U; Milano A; Mazzucco A; Guerra F; Magni A; Santini F; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):415-20. PubMed ID: 2918737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical results after combined aortic and mitral valve replacement.
    Lindblom D; Lindblom U; Aberg B
    Eur J Cardiothorac Surg; 1988; 2(5):347-54. PubMed ID: 3272239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Porcine valvular bioprosthesis. Results 6 years later].
    Vassal T; Leroy G; Desnos M; Fernandez F; Gay J
    Arch Mal Coeur Vaiss; 1987 Feb; 80(2):133-41. PubMed ID: 3107499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of the valve position on the complications related to pericardial Carpentier-Edwards valve after 8 years].
    Aupart M; Dreyfus X; Meurisse Y; May MA; Sirinelli A; Marchand M
    Arch Mal Coeur Vaiss; 1995 Jul; 88(7):967-71. PubMed ID: 7487327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.